Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte protection pathways" collectively refers to a network of signaling mechanisms that preserve hepatocyte viability and support liver regeneration and repair following various injuries, including toxic, infectious, autoimmune, or ischemic insults. Key pathways include cytokine signaling (such as IL-6–gp130–STAT3), growth factor signals (Hepatocyte growth factor, Epidermal growth factor, FGF), Wnt/β-catenin, PI3K-AKT-mTOR, Hippo, and others[1][2][3][4][5][7]. These processes modulate inflammation, apoptosis, proliferation, metabolism, and fibrotic response and are fundamental for maintaining liver health and enabling recovery after damage. While each pathway may contain specific druggable targets (such as IL-6 receptor, HGF receptor [MET], or β-catenin), "hepatocyte protection pathways" itself is not used as a single molecular or therapeutic target in biology or medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte protection pathways.